StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLAW) fundamentals chart

ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-2.08%)

Close on Nov 18, 2026Market cap $14.48MP/E –Yield –

Fundamental chart

Pick a measure to chart its full history

-$7.31MFY2024

See a number that looks wrong?